The emerging role of oral nicotine pouches in tobacco harm reduction.
Level 5 - mechanism / opinion, no new human data
Narrative review and expert opinion summarizing existing literature without systematic review methodology or new human data.
PubMed 41441963 · doi:10.1007/s11739-025-04237-2
What was done
This narrative review synthesized literature on oral nicotine pouches (ONPs) as a tobacco harm reduction strategy, evaluating their chemical composition, toxicological and biomarker profiles, preclinical safety, epidemiological precedents from snus, adult versus youth uptake patterns, and global regulatory approaches.
What was found
The abstract reports no numerical findings or effect sizes. Qualitatively, it states that ONPs eliminate combustion and tobacco leaf, lowering exposure to carcinogens such as tobacco-specific nitrosamines to near-undetectable levels with minimal cytotoxic or inflammatory effects in preclinical testing. It also reports that current adoption is primarily among adult smokers and smokeless tobacco users seeking lower-risk alternatives.
Why it matters
This review outlines the potential of ONPs as a non-combustible substitute for cigarettes that significantly reduces toxicant exposure, which may offer a pragmatic harm-reduction tool where conventional cessation services are limited.
Limits
The abstract describes a non-systematic narrative review with no quantitative data, search parameters, or study counts provided. Much of the population-level health argument relies on indirect extrapolation from Swedish snus rather than long-term longitudinal outcome data on modern ONPs. Issues regarding potential youth uptake, nicotine addiction, and disparate global regulatory policies remain unresolved.